Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Abstract This large community-based cohort study investigates the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), specifically Liraglutide and Semaglutide, on the risk of developing psychiatric conditions such as depression, anxiety, and suicidal behaviors in patients with obesity
Discussion In this article, we reviewed pre-clinical and mechanistic studies (in vitro, in animal and in human) and clinical studies, leveraging potential translational aspects, on GLP-1RAs across a variety of cognitive and mental health disorders
49 GLP-1RAs represent a pharmacotherapeutic category of injectable hypoglycemic agents that are sanctioned as adjunctive therapies to diet and exercise for the management of type 2 diabetes mellitus (T2DM) in adult patients and potentially hold promise in addressing other medical conditions
And these arent experimental drugs, for what its worth
US$ 20.41
US$ 21.05
US$ 29.27
US$ 22.66
US$ 26.55
US$ 26.38
US$ 26.01
US$ 21.53
US$ 23.11
US$ 25.91
US$ 27.12
